Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/42171
Title: Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare
Authors: CUNHA, Mateus TrinconiCARVALHO, Vinicius JardimLOUREIRO, Rafael MaffeiBRANTIS-DE-CARVALHO, Carlos EduardoCINTRA, Murilo BicudoCASTRO JUNIOR, Gilberto de
Citation: JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, n.7, article ID e003044, 2p, 2021
Abstract: A commentary on the original research article: 'Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers'. Of note, the predictor selection process, the cross-validation method, along with the lack of final testing of the developed model with a separated data set may mask overfitting, overestimating performance metrics.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MDR
Departamento de Radiologia - FM/MDR

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - LIM/24
LIM/24 - Laboratório de Oncologia Experimental

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_CUNHA_Letter_to_the_editor_radiomics_analysis_for_predicting_2021.PDFpublishedVersion (English)247.02 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.